drugset / Trial / NCT00771316
Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to demonstrate that MK0826 is comparable to Meropenem in the treatment of complicated Urinary Tract Infections (UTIs) in adults.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ertapenem | Small molecule | 1 g | Intravenous |
| Comparator | Meropenem | Small molecule | 500 mg | Intravenous |